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Abstract 
Background: In an abdominal symptom study in primary care in six European countries, 511 cases of cancer were 
recorded prospectively among 61,802 patients 16 years and older in Norway, Denmark, Sweden, Netherlands, 
Belgium and Scotland. Colorectal cancer is one of the main types of cancer associated with abdominal symptoms; 
hence, an in-depth subgroup analysis of the 94 colorectal cancers was carried out in order to study variation in symp-
tom presentation among cancers in different anatomical locations.
Method: Initial data capture was by completion of standardised forms containing closed questions about symptoms 
recorded during the consultation. Follow-up data were provided by the GP after diagnosis, based on medical record 
data made after the consultation. GPs also provided free text comments about the diagnostic procedure for individual 
patients. Fisher’s exact test was used to analyse differences between groups.
Results: Almost all symptoms recorded could indicate colorectal cancer. ‘Rectal bleeding’ had a specificity of 99.4% 
and a PPV of 4.0%. Faecal occult blood in stool (FOBT) or anaemia may indicate gastrointestinal bleeding: when these 
symptoms and signs were combined, sensitivity reached 57.5%, with 69.2% for cancer in the distal colon. For proximal 
colon cancers, none of 18 patients had ‘Rectal bleeding’ at the initial consultation, but three of the 18 did so at a later 
consultation. ‘Abdominal pain, lower part’, ‘Constipation’ and ‘Distended abdomen, bloating’ were less specific and also 
less sensitive than ‘Rectal bleeding’, and with PPV between 0.7% and 1.9%.
Conclusions: Apart from rectal bleeding, single symptoms did not reach the PPV 3% NICE threshold. However, sup-
plementary information such as a positive FOBT or persistent symptoms may revise the PPV upwards. If a colorectal 
cancer is suspected by the GP despite few symptoms, the total clinical picture may still reach the NICE PPV threshold 
of 3% and justify a specific referral.
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Background
Globally, one in ten cases of new cancer is a colorec-
tal cancer, and death from these cancers reaches almost 
the same proportion [1]. About half of colorectal can-
cer patients in the UK meet the UK National Institute 
for Health and Care Excellence (NICE) referral guide-
lines [2] and are diagnosed within three months after the 
first consultation in general practice [3]. However, the 
remainder often have atypical symptoms and longer diag-
nostic intervals [3]. Colorectal cancer is among the most 
frequently missed diagnoses in primary care [4]. This is a 
challenge for GPs in all countries.
We studied the relationship between abdominal 
symptoms and cancer in a cohort study with prospec-
tive registration of cancer. In two previous articles, we 
described the frequency of abdominal symptoms in 
general practice consultations, and what the general 
practitioner (GP) thought and did in relation to pos-
sible cancer [5]. The relationship between a symptom 
and a cancer diagnosis was also described [6]. This arti-
cle focuses on symptoms and pathways to diagnosis 




Between 25 February 2011 and 27 July 2011, GPs 
recruited through The Cancer and Primary Care 
Research International Network (Ca-PRI), registered 
67,809 consecutive consultations with 61,802 patients 
16 years and older in Norway, Denmark, Sweden, Neth-
erlands, Belgium and Scotland. For initial registrations, 
participating GPs received a desktop workbook con-
taining standardised daily registration sheets, one for 
each of ten working days (Additional file 1) with closed 
questions about symptoms recorded during the con-
sultation [5]. Instructions were provided about how to 
record the different abdominal symptoms. For exam-
ple, ‘Rectal bleeding’ should refer to bleeding “that can 
be observed or suspected macroscopically, either with 
red colour or melaena”. For patients with any specified 
abdominal symptom, non-specific symptoms and fur-
ther diagnostic action were also recorded. Abdominal 
and non-specific symptoms listed were chosen from 
current medical literature related to cancer diagnosis in 
primary care.
Follow‑up
Eight months after each GP’s consultation period, 
GPs who had completed the initial registration sheets 
received forms for recording details of patients diag-
nosed with a new or recurring cancer after the con-
sultation date (Additional file  2). The GPs were given 
their individual consultation dates and used their elec-
tronic records to identify these patients. The form was 
a simplified and revised version of a form used in two 
previous studies [7, 8]. All GPs were asked to supply 
anonymous information about the patients diagnosed 
with cancer during the follow-up period, whether or not 
they had presented symptoms during the initial survey. 
Free text comments accompanied multiple choice infor-
mation about the diagnostic process, especially the role 
of clinical examination, laboratory tests ordered by the 
GP, and diagnostic procedures performed or ordered 
by the GP. Further symptoms, described in the medical 
record and originating between the consultation date 
and the date of diagnosis, were mainly reported in the 
GPs’ free text comments, especially answers to “Write 
in short form what primarily made you (or another phy-
sician) suspect cancer in this particular patient”. Most 
free text descriptions allowed transformation of “After 
consultation” symptoms into one of the pre-registered 
symptoms used in the initial registration forms. There 
were two special cases: “Abdominal pain” or “Acute 
abdomen” was registered as both ‘Abdominal pain, 
upper part’ and ‘Abdominal pain, lower part’, provided 
none of these symptoms had been recorded at consulta-
tion. Similarly, “Changes in bowel habit” was registered 
as both ‘Constipation’ and ‘Diarrhoea’. Two reminders 
were sent to GPs.
Sensitivity and specificity were calculated as the main 
measures of diagnostic accuracy, and positive predictive 
value suggested the probability of cancer. Only positive 
information from the questinnaires was used.
Statistics
Statistical analyses were performed using SPSS, version 
22. Fisher’s exact test was used to analyse differences 
between groups.
In addition to our own analyses, we added a pooled 
analysis of symptoms from our own material plus data 
from another primary care article [9] investigating symp-
tom differences between proximal and distal colon can-
cer, and between colon and rectal cancer.
We used the STARD checklist when writing our report 
[10].
Results
Four hundred ninety-three GPs completed the initial 
registration sheets. 315 (64%) GPs returned follow-up 
forms for one or more subsequent cancer patients. The 
last patient reported with cancer was diagnosed in April 
2012. Among 511 patients with cancer, 65 patients had 
colon cancer and 29 had rectal cancer. Of these, 70 (14%), 
eight (12%) and six (21%) patients, respectively, had can-
cer recurrence.
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The most predominant abdominal symptoms recorded
Table 1 shows a great variety of pre-diagnostic symptoms 
recorded in the 511 cancer patients and in the subgroups 
of patients with subsequent colorectal cancer, new or 
recurrent, at the initial consultation or only at a later 
consultation. Among the 65 patients with colon cancer, 
18 (28%) of the tumours were located in the right (proxi-
mal) colon, 26 (40%) in the left (distal) colon, while this 
was unclear for 21 (32%) patients. ‘Rectal bleeding’ and 
‘Abdominal pain’, both upper and lower, were the most 
frequent symptoms: ‘Rectal bleeding’ was seen espe-
cially in the rectal cancer patients. ‘Constipation’, ‘Diar-
rhoea’ and the three non-specific symptoms were also 
frequently recorded. At least one symptom was recorded 
for 13 of the 18 patients with proximal colon cancer, and 
for 25 of 26 patients with distal colon cancer. Given any 
abdominal symptom recording, 19 of 55 (35%) colon can-
cer patients and 7 of 25 (28%) of rectal cancer patients 
also had non-specific symptoms.
Bleeding from the intestines is shown in Table 2. Speci-
ficity for ‘Rectal bleeding’ reached 99.4%. PPV was 4.0% 
for colorectal cancer, but below 3% for the specific colo-
rectal locations. However, the low number of patients in 
subgroups gave wide confidence intervals, and sex differ-
ences were not significant. For the subgroup of females 
75 years of age or older, six patients had rectal bleeding 
and cancer at consultation, and PPV reached 11.1% for 
colorectal cancer. At consultation, none of the proximal 
colon cancer patients presented ‘Rectal bleeding’, while 
27.6% of rectal cancer patients and 23.1% of distal colon 
cancer patients presented with this symptom. Sensitiv-
ity for colorectal cancer increased from 17.0% for ‘Rec-
tal bleeding’ recordings at initial consultation, to 39.4% 
when symptoms recorded at subsequent consultations 
were taken into account. Adding information about 
positive test for occult blood in stool (FOBT) and/or the 
presence of anaemia, in patients without any recording 
of ‘Rectal bleeding’, sensitivity for one or more of these 
symptoms/signs increased to 57.5%; to 69.2% for cancer 
of the distal colon and to 38.9% for proximal cancer.
Three of the other frequent symptoms have been ana-
lysed in Table 3. ‘Abdominal pain, lower part’, ‘Constipa-
tion’ and ‘Distended abdomen, bloating’ were less specific 
and also less sensitive than ‘Rectal bleeding’, and with a 
lower PPV. However, the symptoms were important for 
diagnosis in many patients, with little difference between 
proximal and distal colon cancer patients.
The initiation of the diagnostic process
The majority of patients were symptomatic (Table 4). Fast 
track referral was used for 26% of patients with colon 
cancer and 38% of patients with rectal cancer. Urgent 
referral was used for 16% of colorectal cancer patients: 
for five patients with subsequent diagnosis of proximal 
colon cancer, two with distal colon cancer, five non-spec-
ified, and three patients with rectal cancer. A GP referred 
the patient in 51 cases (78%) of colon cancer and 26 cases 
(90%) of rectal cancer. The diagnostic process was initi-
ated during the initial consultation in 3 of 18 cases (17%) 
with proximal location, and in 14 of 26 (54%) with distal 
location (P = 0,026); for rectal cancer in 12 of 29 (41%) 
patients. Hospital doctors initiated the search for cancer 
in 18% of colon cancer cases but in 28% with proximal 
location (not significant).
The diagnostic role of the GP’s clinical examination, 
laboratory tests and diagnostic procedures, performed 
or ordered by the GP, and the seriousness of disease
Abdominal examination contributed to the diagnosis in 
about one third of the patients, for colon as well as rec-
tal cancer (Table  5). Digital examination had a similar 
importance as abdominal examination in rectal cancer, 
and somewhat less for colon cancer patients. Proctos-
copy/sigmoidoscopy contributed for 16% of patients, 
about equally for colon and rectal cancer. In 41% of 
patients, there was no diagnostic contribution from the 
clinical examination.
The most important laboratory investigations were 
Haemoglobin (Hb) concentration and Faecal occult 
blood test (FOBT), mainly in colon cancer patients; one 
with proximal and eight with distal colon cancer. Labo-
ratory tests did not contribute to diagnosis in 45% with 
colon cancer and in 62% with rectal cancer.
Coloscopy was diagnostically useful for about 70% of 
patients, for both colon and rectal cancers. Computer 
tomography (CT) examination contributed to the diag-
nosis in 31% of colon cancer patients and 17% of rectal 
cancers.
Colon cancer was localised in 45% of patients, and in 
68% the treatment intention was curative. For rectal can-
cer, these figures were 34% and 76%, respectively. Table 6 
shows that the number of symptoms had little relation-
ship with how localised or spread the cancer was at the 
time of diagnosis. Among the 11 colon cancer patients 
with no symptoms, four had proximal, one distal and six 
unspecified cancer.
Pooled analysis of symptoms
Differences between proximal and distal cancer, and 
between colon and rectal cancer, did not reach signifi-
cance for our data. However, we found one previous 
general practice-based study of symptom differences 
between cancers in the proximal and the more dis-
tal parts of colon, reporting a scarcity of bleeding and 
change in bowel habits in proximal colon cancer (rectal 
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bleeding: three cases of 22), compared with sigmoid (15 
cases of 40) and rectal (40 cases of 57) cancers [9]. It 
was possible to pool data on rectal bleeding at refer-
ral from that study with our data on rectal bleeding at 
consultation. For pooled data, there were significant 
differences between proximal and distal colon cancer 
(P = 0.0038, two-tailed Fisher’s exact test), and between 
colon and rectal cancer (P < 0.0001). In both cases, 




Most abdominal symptoms investigated had a potential 
role in the detection of colorectal cancer. The high speci-
ficity of rectal bleeding for this form of cancer gives GPs a 
good reason for always seeking an explanation in patients 
with this symptom. A positive test for FOBT or iron-
deficiency anaemia increases sensitivity for colorectal 
cancer. Maximising sensitivity is commonly considered 
as a wise diagnostic strategy as long as the lowering of 
specificity does not create an unacceptable false positive 
rate [11]. There is no clear distinction between definite 
alarm symptoms and lower risk symptoms, but abdomi-
nal pain and constipation stand out as among the more 
frequently presenting symptoms. Constipation com-
bines high specificity with relatively high sensitivity and 
seems to be equally important for rectal cancer and colon 
cancer. Another important finding from the study is the 
relatively high specificity and sensitivity of ‘distended 
abdomen, bloating’, mostly recorded in rectal cancer and 
distal colon cancer.
Data about characteristics of symptoms stemming from 
the distal or proximal part of colon are based on relatively 
few cases, with wide confidence intervals for sensitivity 
and PPV. However, altogether they suggest that the GP 
should direct special attention towards the possibility of 
proximal colon cancer when symptoms are vague. The 
scarcity of rectal bleeding from cancers diagnosed in 
this location gives increased importance to the detection 
of possible bleeding through anaemia or FOBT. Unfor-
tunately, FOBT has been shown to have slightly lower 
sensitivity for proximal than for distal colon cancer [12]. 
We did not ask whether guaiac-based tests or qualitative 
faecal immunochemical tests (FITs) were used. There 
is some evidence that the latter kind of test has higher 
accuracy than traditional tests, and combining FITs with 
the assessment of haemoglobin levels could improve sen-
sitivity [13].
It should be noted that not all participating countries 
had established fast track pathways for colorectal can-
cer at the time of this study, Still, our study suggests that 
patients with proximal colon cancer seem to get less 
fast track referrals, have more urgent referrals, are per-
haps more often discovered by hospital doctors and the 
diagnostic process is less frequently initiated by the GP 
at consultation. Scarcity or slow debut of symptoms, 
slow development of anaemia, fewer positive findings on 
clinical examination, insufficiency of sigmoidoscopy may 
contribute to this. Proximal colon cancer is less common 
than distal cancer, but the difference is perhaps smaller 
than many GPs think, 46 vs 54% in an Icelandic study 
[14]. Follow-up consultations in general practice may 
prove important as a start.
Clinical examination remains a mainstay of GP activity 
[15], and clinical findings as well as laboratory findings 
may each have had diagnostic importance for more than 
half of the colorectal patients. Diagnostic thinking mostly 
starts with symptoms which often give good diagnostic 
cues: however, a GP who routinely performs a simple but 
Table 4 Number of patients with symptomatic or asymptomatic initiation of the diagnostic process of colorectal cancer, in relation to 
location for colon cancer. Cohort study with 61,802 patients in primary care (2011–12)
PC Primary care, SC Specialist/hospital care
Type of referral / Location of cancer Colon Cancer Rectal cancer
Proximal (n = 18) Distal (n = 26) Unspecified (n = 21) (n = 29)
A. Symptomatic patients (Colon 57, rectum 28)
PC, ordinary referral (Colon 24, Rectum 13) 5 12 7 13
PC, fast track referral (Colon 17, Rectum 11) 4 7 6 11
PC, urgent referral (Colon 12, Rectum 3) 5 2 5 3
SC, no referral (Colon 4, Rectum 1)) 2 2 1
B. Asymptomatic patients (Colon 8, Rectum 1)
Screening (Colon 2, Rectum 1) 2 1
Incidentally (Colon 5) 2 1 2
Do not know (Colon 1) 1
Page 9 of 13Holtedahl et al. BMC Fam Pract          (2021) 22:148  
focused examination related to the medical history, may 
achieve new and sometimes unexpected insights. In one 
Danish study, abnormal laboratory values were associ-
ated with underlying cancer and could raise cancer sus-
picion [16]. Sensitivity of the total diagnostic picture may 
increase [8], i.e. a higher proportion of the GP’s patients 
presents with one or another type of ‘clue’ to diagnosis. 
Most GPs are aware that a negative digital rectal palpa-
tion has limited value in the detection of rectal tumours 
[17].
Colorectal cancer is among the cancers where early 
diagnosis has the highest impact on survival [18]. 
Patients in this study were most frequently diagnosed at 
a stage when there was still a hope of cure. The symptoms 
described often occur before the tumour has metasta-
sised [19]. GPs thus have a crucial role in the colorectal 
cancer diagnostic pathways [20].
Strength and limitations of the study
Despite the large cohort size, the number of colorec-
tal patients was less than one hundred, and suggestive 
inferences rather than firm conclusions appear in this 
paper. However, some characteristics of colon cancer 
Table 5 The diagnostic role of clinical examination, laboratory tests and diagnostic procedures, performed or ordered by a general 
practitioner (GP), in colorectal cancer. Number of patients where these had diagnostic importance. Cohort study with 61,802 patients 
in primary care (2011–12)
More than one examination/procedure could be recorded for one patient, where appropriate
Colon cancer (n = 65) Proximal location 
(n = 18)
Distal location (n = 26) Unspecified (n = 21) Rectal cancer (n = 29)
Clinical examination
Abdominal examination 19 (29.2%) 4 (22.2%) 7 (26.9%) 8 (38.1%) 10 (34.5%)
Digital rectal examination 13 (20.0%) 1 (5.6%) 7 (26.9%) 5 (23.8%) 11 (37.9%)
Gynecological examination 1 1 1
Proctoscopy/sigmoidoscopy 10 (15.4%) 1 (5.6%) 6 (23.1%) 3 (14.3%) 5 (17.2%)
Other examination 5 3 2 2
No diagnostic contribution 
from clinical examination
29 (44.6%) 11 (61.1%) 10 (38.5%) 8 (38.1%) 10 (34.5%)
Missing 4 2 1 1 1
Laboratory tests
Haemoglobin concentration 17 (26.2%) 5 (27.8%) 5 (19.2%) 7 (33.3%) 2 (6.9%)
Erythrocyte Sedimentation rate 5 2 3 1
C-Reactive Protein 7 2 2 3 2
Test for occult blood in stool 17 (26.2%) 1 (5.6%) 8 (30.8%) 8 (38.1%) 4 (13.8%)
Cervical cytology 0 0
Prostate Specific Antigen 0 0
Urinary examination 0 0
Other 3 3 2
No diagnostic contribution 
from laboratory tests
29 (44.6%) 10 (55.6%) 13 (50.0%) 6 (28.6%) 18 (62.1%)
Missing 5 1 2 2 3
Diagnostic procedures
X-ray 4 1 2 1 1
Ultrasound 2 2 1
Computer tomography 20 (30.8%) 7 (38.9%) 6 (23.1%) 7 (33.3%) 5 (17.2%)
Magnetic resonance 1 1 4 
Upper GI Endoscopy 0 0
Coloscopy 47 (72.3%) 13 (72.2%) 19 (73.1%) 15 (71.4%) 20 (69.0%)
Cystoscopy 0 0
Other 2 1 1 3
None of the above procedures 6 (9.2%) 2 (11.1%) 3 (11.5%) 1 (4.8%) 1 (3.4%)
Missing 2 1 1 1
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show consistent trends in our tables. The pooled analy-
sis of symptom differences between different locations 
was not planned, and was undertaken only after we 
found the reference to the previous study. That analy-
sis makes it more likely that the lack of significance for 
differences in our symptom data is due to the modest 
number of cases rather than differences not being real. 
It should be possible to outline diagnostic strategies 
based on the assumption that proximal colon cancer is 
indeed often rather symptom-poor.
The prospective nature of the follow-up implies that 
neither the patient nor the GP knew about the cancer 
diagnosis at the time of the initial symptom registra-
tion. In addition to the cross-sectional data recorded 
during the consultation, longitudinal data from medi-
cal records give a fuller picture of which symptoms the 
patient observed before diagnosis. Data from medical 
records are often incomplete, illustrated by the omis-
sion of a precise tumour location in many patients. 
However, this kind of symptom-based data probably 
has a high reliability [21], and a free text comment 
about what made the GP suspect cancer was missing 
for only one rectal cancer patient. For most patients in 
our study, it was possible to understand the approxi-
mate sequence of events leading up to the individual 
diagnosis.
Consecutive patients were registered sequentially and 
there was therefore no selection bias. The patient form 
was simple, with multiple choice answers and room for 
free text comments. For colorectal cancer, GPs seem to 
see most symptomatic patients before the diagnosis has 
been made. The proportion with new colorectal can-
cer (18.1%) was a little higher than for population based 
Norwegian figures (P = 0.016) [22]. There were more 
female patients diagnosed in our study population, rela-
tive to Norwegian incidence figures (P = 0.023 for colon 
cancer, P = 0.125 for rectal cancer). The number of 
patients is low, and we think the higher proportion of 
female patients may be coincidental.
With time, it becomes gradually less probable that 
there is a relationship between a symptom and subse-
quent cancer. In the second article from this study [6], 
we therefore limited analysis to patients with new cancer, 
diagnosed within six months after the consultation. This 
allowed for a more homogeneous group of patients. With 
fewer patients with a colorectal cancer diagnosis, we 
chose to include all patients in the study in the present 
article. Among patients with new cancer, 30% therefore 
were diagnosed more than six months after the consulta-
tion, as shown in Table 1.
Strength and weaknesses in relation to other studies
For colorectal cancer, rectal bleeding, change in bowel 
habit and iron deficiency anaemia have been shown to 
have a PPV > 5% in higher age groups [23]. However, val-
ues this high for single symptoms are infrequent, and the 
UK NICE guidelines use a 3% risk threshold for recom-
mending a suspected cancer pathway referral [24]. Based 
on Bayesian thinking, combinations of symptoms and 
signs may bring the cumulative PPV above 3% [25, 26]. 
Non-specific symptoms have low cancer relevance in 
themselves, but they gain in importance when associated 
with an alarm symptom [27].
Hamilton [28] suggested that referral decisions become 
more difficult for low-risk-but-not-no-risk symp-
toms. Our PPVs for abdominal pain, constipation, and 
Table 6 Symptoms in relation to stage for colorectal cancer
Colon cancer (n = 65) Stage
At consultation After consultation Localised(n = 29) Locally advanced(n = 18) Distant metastases (n = 10) Unknown or Missing(n = 8)
No symptoms No symptoms 3 2 2 4
No symptoms 1–2 symptoms 13 9 2 3
1–2 symptoms No symptoms 6 3 2 1
1–2 symptoms 1–2 symptoms 1 1
3 + symptoms No symptoms 4 4 3
3 + symptoms 1–2 symptoms 2
Rectal cancer (n = 29) Stage
At consultation After consultaton Localised(n = 10) Locally advanced(n = 8) Distant metastases (n = 9) Unknown or Missing(n = 2)
No symptoms No symptoms 1 1 2 1
No symptoms 1–2 symptoms 3 1 2 1
1–2 symptoms No symptoms 2 3 2
1–2 symptoms 1–2 symptoms 1 1
3 + symptoms No symptoms 2 2 2
3 + symptoms 1–2 symptoms 1 1
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distended abdomen, confirm this. However, in com-
bination with other symptoms, PPV may rise. For sin-
gle symptoms, a low PPV in younger age groups may 
increase with increasing age [29]. Previously published 
results from the current study population showed that 
GPs may have justifiable trust in their intuition-based 
cancer suspicion [5], recently confirmed in a meta-
analysis [30]. Therefore, cancer pathway referral may be 
justified in many cases of patients presenting with low-
risk symptoms. Our proportion of patients referred to 
fast-track diagnosis was slightly lower than that found 
for colorectal cancer patients in other studies [31, 32]. 
Diagnostic intervals decrease with dedicated cancer sus-
picion pathways [33, 34]. It is still uncertain whether dif-
ferent forms of fast track [35] lead to survival benefits in 
colorectal cancer [36, 37]. However, a Danish study of 
five common cancers including colorectal cancer, found 
that both the shortest and the longest diagnostic inter-
vals were associated with higher 5-year mortality [38], 
the shortest due to already advanced disease at presenta-
tion. The authors concluded that this supports efforts to 
shorten the longest intervals through fast track pathways.
About 30% of cases of advanced colon neoplasia are 
not detected by sigmoidoscopy [39], while 36.5% of cases 
in a surgical study of malignant large bowel obstruction 
presentation had a right hemicolectomy [40]. Iron defi-
ciency anaemia was the most common clue associated 
with missed opportunities for diagnosis of colorectal 
cancer [41]. A retrospective Icelandic study found that 
three of four patients with proximal colon cancer had 
anaemia, and they were more likely to be diagnosed inci-
dentally than those with distal tumours [14]. Patients 
with non-specific but concerning symptoms were more 
likely than patients with alarm symptoms to be diagnosed 
at a later stage, and via an emergency presentation [42]. 
Rectal bleeding was less common in emergency presen-
tations [43]. All these findings are in line with our find-
ings of diagnostic clues to proximal colon cancer, i.e. less 
overt bleeding and more anaemia, and that diagnosis of 
proximal cancer is often more difficult.
Implications for policy, practice and research
GPs should think about colorectal cancer as a group of 
diseases with three distinct locations. All locations have 
many similar presenting features, but location in the rec-
tum, in the distal or in the proximal part of colon also 
have some distinct characteristics. Location in the proxi-
mal colon, i.e. caecum, appendix, ascending or transver-
sal colon may have less typical symptoms but should raise 
awareness and be systematically assessed when symp-
toms are present but vague. The total clinical picture may 
then reach the NICE PPV threshold of 3% and justify a 
specific referral. To think of a proximal colon cancer 
when symptoms are limited is difficult, but referral may 
point to the possibility of colon cancer in general. Some 
of the GP’s cue may be to remember proximal cancer as 
a possibility when there is uneasiness and other explana-
tions seem unsatisfactory. Such an approach could also 
contribute to earlier diagnosis for some more rare gastro-
intestinal tumours with unpredictable locations, like car-
cinoids or lymphomas.
Most abdominal symptoms merit the GP’s attention 
and efforts to collect more clinical and investigation evi-
dence, in order to better assess the probability of a cancer 
diagnosis. However, an important proportion of can-
cer patients do not have the most common symptoms. 
Because the symptom presentation of colorectal cancer 
has such a wide spectrum, specific referral may be jus-
tified even when the clinical features are not among the 
common ones. Having an alarm symptom seems to give 
the highest probability of being referred to fast track 
routes, more so than the extent to which the GP con-
siders the symptom to be serious [31]. Other cues, like 
positive clinical findings or test results, or ‘low-risk-but-
not-no-risk’ symptoms in many cases should alert the 
GP’s suspicion of cancer and be the starting point of diag-
nostic work.
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